{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:52:19Z","timestamp":1792511539908,"version":"4.5.0"},"posted":{"date-parts":[[2024,3,5]]},"group-title":"In Review","reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,2,23]]},"abstract":"<title>Abstract<\/title>\n        <p>Pathological aggregation of a-synuclein (aS) is implicated in the pathogenesis of Parkinson\u2019s disease (PD) and other a-synucleinopathies. The current view is that neuron-to-neuron spreading of aS pathology contributes to the progression of a-synucleinopathy. We used an A53T mutant human aS transgenic mouse model (<italic>TgA53T<\/italic>) to examine whether the site of pathogenic aS inoculation affects the pattern of neuropathology and whether soluble and insoluble fractions derived from crude pathogenic tissue lysates exhibit differential capacities to initiate aS pathology. To test whether the inoculation site impacts the ultimate spatial\/temporal patterns of aS pathology, aS preformed fibrils (PFF), or brain homogenates from <italic>TgA53T<\/italic> mice with a-synucleinopathy, were injected into the cortex\/striatum, brain stem, or skeletal muscle. In all cases, inoculation of pathogenic aS induced end-stage motor dysfunction within ~100 days post-inoculation (dpi). Significantly, irrespective of the inoculation sites, ultimate distribution of the aS pathology was like that seen in normally aged <italic>TgA53T<\/italic> mice at end-stage, indicating that the intrinsic neuronal vulnerability is a significant determinant in the induction of aS pathology, even when initiated by inoculation of pathogenic aS. Temporal analysis of brain stem injected <italic>TgA53T<\/italic> mice show that initial aS pathology was seen by 30 days post-inoculation and inflammatory changes occur at later stages. To determine if the aS species with differential solubility are differentially pathogenic, brain lysates from end-stage <italic>TgA53T<\/italic>mice were fractionated into highly soluble (S150) and insoluble (P150) fractions, as well as the endoplasmic reticulum (ER)-enriched fraction (P100). Significantly, all fractions were able to seed <italic>de novo<\/italic> aS pathology <italic>in vivo<\/italic>, when injected unilaterally into <italic>TgA53T<\/italic>mice with the ER fractions being most pathogenic. Our results suggest that multiple aS species from brain can initiate the development of progressive aS pathology.<\/p>","DOI":"10.21203\/rs.3.rs-3982325\/v1","type":"posted-content","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T16:57:47Z","timestamp":1709657867000},"source":"Crossref","is-referenced-by-count":1,"title":["Soluble and insoluble lysates from the human A53T mutant \u03b1-synuclein transgenic mouse model induces \u03b1-synucleinopathy independent of injection site"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5865-9682","authenticated-orcid":false,"given":"Michael","family":"Lee","sequence":"first","affiliation":[{"name":"University of Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Barnes","sequence":"additional","affiliation":[{"name":"University of Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Vermilyea","sequence":"additional","affiliation":[{"name":"University of Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Meints","sequence":"additional","affiliation":[{"name":"University of Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Martinez","sequence":"additional","affiliation":[{"name":"University of Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"Suppl","key":"ref1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nm1068","article-title":"Genetic clues to the pathogenesis of Parkinson's disease","volume":"10","author":"Vila M","year":"2004","unstructured":"Vila, M. & Przedborski, S. Genetic clues to the pathogenesis of Parkinson's disease. Nat Med 10 Suppl, S58\u201362 (2004).","journal-title":"Nat Med"},{"key":"ref2","author":"Obeso JA","year":"2010","unstructured":"Obeso, J.A. et al. Missing pieces in the Parkinson's disease puzzle. Nat Med 16, 653\u2009\u2013\u200961 (2010)."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak H","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol Aging"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li JY","year":"2008","unstructured":"Li, J.Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14, 501\u20133 (2008).","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower JH","year":"2008","unstructured":"Kordower, J.H., Chu, Y., Hauser, R.A., Freeman, T.B. & Olanow, C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14, 504\u20136 (2008).","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk KC","year":"2012","unstructured":"Luk, K.C. et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209, 975\u201386 (2012).","journal-title":"J Exp Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14802\/jmd.19046","article-title":"Modeling alpha-Synuclein Propagation with Preformed Fibril Injections","volume":"12","author":"Chung HK","year":"2019","unstructured":"Chung, H.K., Ho, H.A., Perez-Acuna, D. & Lee, S.J. Modeling alpha-Synuclein Propagation with Preformed Fibril Injections. J Mov Disord 12, 139\u2013151 (2019).","journal-title":"J Mov Disord"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee MK","year":"2002","unstructured":"Lee, M.K. et al. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A 99, 8968\u201373 (2002).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40035-022-00309-x","article-title":"Loss of tau expression attenuates neurodegeneration associated with alpha-synucleinopathy","volume":"11","author":"Vermilyea SC","year":"2022","unstructured":"Vermilyea, S.C. et al. Loss of tau expression attenuates neurodegeneration associated with alpha-synucleinopathy. Transl Neurodegener 11, 34 (2022).","journal-title":"Transl Neurodegener"},{"key":"ref10","author":"Braak H","year":"2002","unstructured":"Braak, H. et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249 Suppl 3, III\/1\u20135 (2002)."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-020-00364-w","article-title":"alpha-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment","volume":"15","author":"Karim MR","year":"2020","unstructured":"Karim, M.R. et al. alpha-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment. Mol Neurodegener 15, 27 (2020).","journal-title":"Mol Neurodegener"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0344-18.2018","article-title":"A53T mutant alpha-synuclein induces tau dependent postsynaptic impairment independent of neurodegenerative changes","author":"Teravskis PJ","year":"2018","unstructured":"Teravskis, P.J. et al. A53T mutant alpha-synuclein induces tau dependent postsynaptic impairment independent of neurodegenerative changes. J Neurosci (2018).","journal-title":"J Neurosci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1523\/JNEUROSCI.5367-11.2012","article-title":"Endoplasmic Reticulum Stress Is Important for the Manifestations of alpha-Synucleinopathy In Vivo","volume":"32","author":"Colla E","year":"2012","unstructured":"Colla, E. et al. Endoplasmic Reticulum Stress Is Important for the Manifestations of alpha-Synucleinopathy In Vivo. J Neurosci 32, 3306\u201320 (2012).","journal-title":"J Neurosci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-019-0335-3","article-title":"Microglia affect alpha-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease","volume":"14","author":"George S","year":"2019","unstructured":"George, S. et al. Microglia affect alpha-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease. Mol Neurodegener 14, 34 (2019).","journal-title":"Mol Neurodegener"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-017-0182-z","article-title":"Intrastriatal injection of alpha-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity","volume":"12","author":"Sorrentino ZA","year":"2017","unstructured":"Sorrentino, Z.A. et al. Intrastriatal injection of alpha-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity. Mol Neurodegener 12, 40 (2017).","journal-title":"Mol Neurodegener"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-019-01977-2","article-title":"alpha-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease","volume":"138","author":"Sorrentino ZA","year":"2019","unstructured":"Sorrentino, Z.A., Giasson, B.I. & Chakrabarty, P. alpha-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease. Acta Neuropathol 138, 1\u201321 (2019).","journal-title":"Acta Neuropathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-023-02547-3","article-title":"Dysregulation of astrocytic Ca(2+) signaling and gliotransmitter release in mouse models of alpha-synucleinopathies","volume":"145","author":"Nanclares C","year":"2023","unstructured":"Nanclares, C. et al. Dysregulation of astrocytic Ca(2+) signaling and gliotransmitter release in mouse models of alpha-synucleinopathies. Acta Neuropathol 145, 597\u2013610 (2023).","journal-title":"Acta Neuropathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nbd.2018.09.005","article-title":"Motor neuron loss and neuroinflammation in a model of alpha-synuclein-induced neurodegeneration","volume":"120","author":"Sorrentino ZA","year":"2018","unstructured":"Sorrentino, Z.A. et al. Motor neuron loss and neuroinflammation in a model of alpha-synuclein-induced neurodegeneration. Neurobiol Dis 120, 98\u2013106 (2018).","journal-title":"Neurobiol Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.1074\/jbc.M306390200","article-title":"Proteasomal inhibition by alpha-synuclein filaments and oligomers","volume":"279","author":"Lindersson E","year":"2004","unstructured":"Lindersson, E. et al. Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 279, 12924\u201334 (2004).","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","article-title":"Accumulation of Toxic alpha-Synuclein Oligomer within Endoplasmic Reticulum Occurs in alpha-Synucleinopathy In Vivo","volume":"32","author":"Colla E","year":"2012","unstructured":"Colla, E. et al. Accumulation of Toxic alpha-Synuclein Oligomer within Endoplasmic Reticulum Occurs in alpha-Synucleinopathy In Vivo. J Neurosci 32, 3301\u20135 (2012).","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-2-18","article-title":"Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers","volume":"2","author":"Kayed R","year":"2007","unstructured":"Kayed, R. et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 2, 18 (2007).","journal-title":"Mol Neurodegener"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2017.12.004","article-title":"Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons","volume":"111","author":"Colla E","year":"2018","unstructured":"Colla, E. et al. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons. Neurobiology of Disease 111, 36\u201347 (2018).","journal-title":"Neurobiology of Disease"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/jnc.14779","article-title":"Spreading of alpha-synuclein - relevant or epiphenomenon?","volume":"150","author":"Killinger BA","year":"2019","unstructured":"Killinger, B.A. & Kordower, J.H. Spreading of alpha-synuclein - relevant or epiphenomenon? J Neurochem 150, 605\u2013611 (2019).","journal-title":"J Neurochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41531-024-00640-2","article-title":"Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson's disease mouse model","volume":"10","author":"Lai Thi","year":"2024","unstructured":"Thi Lai, T. et al. Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson's disease mouse model. NPJ Parkinsons Dis 10, 32 (2024).","journal-title":"NPJ Parkinsons Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations","volume":"102","author":"Li W","year":"2005","unstructured":"Li, W. et al. Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc Natl Acad Sci U S A 102, 2162\u20137 (2005).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","author":"Sonustun B","year":"2022","unstructured":"Sonustun, B. et al. Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson's Disease and Multiple System Atrophy. Cells 11(2022)."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-022-01239-7","article-title":"Post-translational modifications of soluble alpha-synuclein regulate the amplification of pathological alpha-synuclein","volume":"26","author":"Zhang S","year":"2023","unstructured":"Zhang, S. et al. Post-translational modifications of soluble alpha-synuclein regulate the amplification of pathological alpha-synuclein. Nat Neurosci 26, 213\u2013225 (2023).","journal-title":"Nat Neurosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00401-022-02425-4","article-title":"Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human alpha-synuclein transgenic mice","volume":"143","author":"Lloyd GM","year":"2022","unstructured":"Lloyd, G.M. et al. Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human alpha-synuclein transgenic mice. Acta Neuropathol 143, 663\u2013685 (2022).","journal-title":"Acta Neuropathol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3982325\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3982325\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:08:32Z","timestamp":1751468912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3982325\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":28,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3982325\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.3390\/ijms26136254","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,3,5]]},"subtype":"preprint"}}